Profile data is unavailable for this security.
About the company
China Resources Jiangzhong Pharmaceutical Co Ltd, formerly Jiang Zhong Pharmaceutical Co Ltd, is a China-based company mainly engaged in the pharmaceutical manufacturing industry. The Company's products are classified into over-the-counter (OTC) drugs, prescription drugs, big health products and others, covering spleen and stomach, intestines, throat, tonic, rehabilitation nutrition, high-end tonic, cardiovascular and cerebrovascular, gynecology, urinary system and other fields. OTC products include Jianweixiaoshi Tablets, Lactobacillus Tablets, Compound Coral Grass Tablets, and Bifidobacterium Triple Live Enteric Capsules. Health products mainly include peptides and protein powder products. Prescription drug products include Chinese medicine products such as Bazhen Yimu Capsules, Shenbao Capsules, Paishi Granules, Huangqi Shengmai Yin, Zhenju Jiangya Tablets, Shuangju Granules, Zhikang Tablets, Shuxiong Granules and others.
- Revenue in CNY (TTM)4.40bn
- Net income in CNY837.30m
- Incorporated1996
- Employees4.18k
- LocationJiang Zhong Pharmaceutical Co LtdNo. 788, Huoju Avenue, High-Tech ZoneNANCHANG 330096ChinaCHN
- Phone+86 79 188169323
- Fax+86 79 188162532
- Websitehttp://www.jzjt.com/
Mergers & acquisitions
| Acquired company | 600750:SHH since announced | Transaction value |
|---|---|---|
| Anhui Jingcheng Huiyao Pharmaceutical Co Ltd | 14.50% | 9.92m |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shanghai Haoyuan Chemexpress Co Ltd | 2.71bn | 294.90m | 14.95bn | 3.58k | 50.51 | 4.80 | -- | 5.52 | 1.40 | 1.40 | 12.85 | 14.67 | 0.504 | 1.10 | 3.98 | 757,880.40 | 5.37 | 5.94 | 7.32 | 7.80 | 48.93 | 45.09 | 10.66 | 11.74 | 1.46 | 7.54 | 0.4102 | 16.95 | 20.75 | 40.89 | 58.17 | 22.38 | 71.42 | -- |
| Zhejiang Medicine Co Ltd | 8.96bn | 1.24bn | 15.41bn | 5.82k | 12.39 | 1.39 | -- | 1.72 | 1.29 | 1.29 | 9.31 | 11.50 | 0.6499 | 2.76 | 5.65 | 1,540,449.00 | 8.19 | 5.31 | 10.15 | 6.93 | 39.47 | 36.97 | 12.60 | 7.68 | 2.01 | -- | 0.0784 | 30.91 | 20.29 | 5.88 | 170.11 | 27.62 | 3.74 | -18.03 |
| Zhejiang Jiuzhou Pharmaceutical Co Ltd | 5.36bn | 722.87m | 15.61bn | 5.00k | 21.63 | 1.78 | -- | 2.91 | 0.8113 | 0.8113 | 6.07 | 9.84 | 0.493 | 1.97 | 4.84 | 1,070,948.00 | 6.65 | 9.23 | 7.91 | 12.19 | 34.65 | 33.78 | 13.50 | 15.64 | 2.42 | -- | 0.0152 | 39.55 | -6.57 | 20.67 | -41.34 | 20.58 | 22.64 | 8.45 |
| China Resources Jingzhng Phrmctcl Co Ltd | 4.40bn | 837.30m | 15.85bn | 4.18k | 18.88 | 4.18 | -- | 3.60 | 1.32 | 1.32 | 6.94 | 5.98 | 0.6755 | 3.53 | 11.30 | 1,051,350.00 | 14.12 | 11.45 | 23.31 | 16.72 | 60.96 | 64.04 | 20.91 | 18.23 | 1.33 | -- | 0.0348 | 93.25 | -2.59 | 12.61 | 9.67 | 11.20 | 30.67 | 36.85 |
| Nanjing King-Frind Bchmcl Phrmctcl C Ltd | 3.76bn | 649.83m | 15.88bn | 1.36k | 24.10 | 2.35 | -- | 4.22 | 0.4079 | 0.4079 | 2.35 | 4.18 | 0.3812 | 0.6322 | 3.82 | 2,765,677.00 | 6.59 | 8.38 | 8.99 | 12.03 | 41.12 | 44.95 | 17.28 | 19.72 | 1.35 | -- | 0.2644 | 23.22 | -0.1984 | 9.70 | 536.09 | 6.43 | 34.44 | -6.04 |
| Guobang Pharma Ltd | 5.94bn | 872.95m | 15.96bn | 4.00k | 18.19 | 1.93 | -- | 2.69 | 1.57 | 1.57 | 10.68 | 14.80 | 0.5603 | 3.06 | 7.04 | 1,484,531.00 | 8.20 | 9.52 | 10.33 | 12.47 | 24.67 | 27.10 | 14.64 | 14.91 | 2.30 | -- | 0.1038 | 24.76 | 10.12 | 9.15 | 27.61 | 19.94 | -7.08 | -- |
| Tonghua Dongbao Pharmaceutical Co Ltd | 2.74bn | 1.23bn | 17.04bn | 3.41k | 13.87 | 2.39 | -- | 6.22 | 0.6271 | 0.6271 | 1.40 | 3.64 | 0.3589 | 1.05 | 5.11 | 803,924.60 | 15.84 | 14.89 | 17.08 | 15.68 | 71.05 | 78.86 | 44.15 | 35.26 | 3.49 | -- | 0.0988 | 50.60 | -34.66 | -6.27 | -103.66 | -- | 14.17 | 4.56 |
| Holder | Shares | % Held |
|---|---|---|
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 32.30m | 5.18% |
| China Investment Corp. (Investment Management)as of 30 Jun 2025 | 15.55m | 2.49% |
| Sunshine Life Insurance Co. Ltd. (Investment Portfolio)as of 30 Jun 2025 | 11.62m | 1.86% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2025 | 3.53m | 0.57% |
| China Asset Management Co., Ltd.as of 30 Jun 2025 | 2.86m | 0.46% |
| Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)as of 30 Jun 2025 | 2.80m | 0.45% |
| Tian Hong Asset Management Co., Ltd.as of 30 Jun 2025 | 2.60m | 0.42% |
| First Seafront Fund Management Co., Ltd.as of 30 Jun 2025 | 2.51m | 0.40% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 1.77m | 0.28% |
| The Vanguard Group, Inc.as of 04 Feb 2026 | 1.75m | 0.28% |
